Point-of-Care Infectious Disease Diagnostics Market Size, Share, and Trends 2026 to 2035

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology (Premium Insights)

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Point-of-Care Infectious Disease Diagnostics Market 

5.1. COVID-19 Landscape: Point-of-Care Infectious Disease Diagnostics Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Point-of-Care Infectious Disease Diagnostics Market, By Technology

8.1. Point-of-Care Infectious Disease Diagnostics Market, by Technology

8.1.1 Lateral Flow

8.1.1.1. Market Revenue and Forecast

8.1.2. Agglutination Assays

8.1.2.1. Market Revenue and Forecast

8.1.3. Flow Through

8.1.3.1. Market Revenue and Forecast

8.1.4. Solid Phase

8.1.4.1. Market Revenue and Forecast

Chapter 9. Global Point-of-Care Infectious Disease Diagnostics Market, By Application

9.1. Point-of-Care Infectious Disease Diagnostics Market, by Application

9.1.1. HIV

9.1.1.1. Market Revenue and Forecast

9.1.2. Liver Disease

9.1.2.1. Market Revenue and Forecast

9.1.3. Tropical Disease

9.1.3.1. Market Revenue and Forecast

9.1.4. Inflammatory Disease

9.1.4.1. Market Revenue and Forecast

9.1.5. Respiratory Disease

9.1.5.1. Market Revenue and Forecast

9.1.6. Hospital Associated Infections (HAIs)

9.1.6.1. Market Revenue and Forecast

9.1.7. Sexual Health Disorders

9.1.7.1. Market Revenue and Forecast

9.1.8. Others

9.1.8.1. Market Revenue and Forecast

Chapter 10. Global Point-of-Care Infectious Disease Diagnostics Market, By End-user 

10.1. Point-of-Care Infectious Disease Diagnostics Market, by End-user

10.1.1. Hospital

10.1.1.1. Market Revenue and Forecast

10.1.2. Diagnostic Laboratories

10.1.2.1. Market Revenue and Forecast

10.1.3. Home-care settings

10.1.3.1. Market Revenue and Forecast

10.1.4. Others

10.1.4.1. Market Revenue and Forecast

Chapter 11. Global Point-of-Care Infectious Disease Diagnostics Market, Regional Estimates and Trend Forecast

11.1. North America

11.1.1. Market Revenue and Forecast, by Technology

11.1.2. Market Revenue and Forecast, by Application

11.1.3. Market Revenue and Forecast, by End-user

11.1.4. U.S.

11.1.4.1. Market Revenue and Forecast, by Technology

11.1.4.2. Market Revenue and Forecast, by Application

11.1.4.3. Market Revenue and Forecast, by End-user

11.1.5. Rest of North America

11.1.5.1. Market Revenue and Forecast, by Technology

11.1.5.2. Market Revenue and Forecast, by Application

11.1.5.3. Market Revenue and Forecast, by End-user

11.2. Europe

11.2.1. Market Revenue and Forecast, by Technology

11.2.2. Market Revenue and Forecast, by Application

11.2.3. Market Revenue and Forecast, by End-user

11.2.4. UK

11.2.4.1. Market Revenue and Forecast, by Technology

11.2.4.2. Market Revenue and Forecast, by Application

11.2.4.3. Market Revenue and Forecast, by End-user

11.2.5. Germany

11.2.5.1. Market Revenue and Forecast, by Technology

11.2.5.2. Market Revenue and Forecast, by Application

11.2.5.3. Market Revenue and Forecast, by End-user

11.2.6. France

11.2.6.1. Market Revenue and Forecast, by Technology

11.2.6.2. Market Revenue and Forecast, by Application

11.2.6.3. Market Revenue and Forecast, by End-user

11.2.7. Rest of Europe

11.2.7.1. Market Revenue and Forecast, by Technology

11.2.7.2. Market Revenue and Forecast, by Application

11.2.7.3. Market Revenue and Forecast, by End-user

11.3. APAC

11.3.1. Market Revenue and Forecast, by Technology

11.3.2. Market Revenue and Forecast, by Application

11.3.3. Market Revenue and Forecast, by End-user

11.3.4. India

11.3.4.1. Market Revenue and Forecast, by Technology

11.3.4.2. Market Revenue and Forecast, by Application

11.3.4.3. Market Revenue and Forecast, by End-user

11.3.5. China

11.3.5.1. Market Revenue and Forecast, by Technology

11.3.5.2. Market Revenue and Forecast, by Application

11.3.5.3. Market Revenue and Forecast, by End-user

11.3.6. Japan

11.3.6.1. Market Revenue and Forecast, by Technology

11.3.6.2. Market Revenue and Forecast, by Application

11.3.6.3. Market Revenue and Forecast, by End-user

11.3.7. Rest of APAC

11.3.7.1. Market Revenue and Forecast, by Technology

11.3.7.2. Market Revenue and Forecast, by Application

11.3.7.3. Market Revenue and Forecast, by End-user

11.4. MEA

11.4.1. Market Revenue and Forecast, by Technology

11.4.2. Market Revenue and Forecast, by Application

11.4.3. Market Revenue and Forecast, by End-user

11.4.4. GCC

11.4.4.1. Market Revenue and Forecast, by Technology

11.4.4.2. Market Revenue and Forecast, by Application

11.4.4.3. Market Revenue and Forecast, by End-user

11.4.5. North Africa

11.4.5.1. Market Revenue and Forecast, by Technology

11.4.5.2. Market Revenue and Forecast, by Application

11.4.5.3. Market Revenue and Forecast, by End-user

11.4.6. South Africa

11.4.6.1. Market Revenue and Forecast, by Technology

11.4.6.2. Market Revenue and Forecast, by Application

11.4.6.3. Market Revenue and Forecast, by End-user

11.4.7. Rest of MEA

11.4.7.1. Market Revenue and Forecast, by Technology

11.4.7.2. Market Revenue and Forecast, by Application

11.4.7.3. Market Revenue and Forecast, by End-user

11.5. Latin America

11.5.1. Market Revenue and Forecast, by Technology

11.5.2. Market Revenue and Forecast, by Application

11.5.3. Market Revenue and Forecast, by End-user

11.5.4. Brazil

11.5.4.1. Market Revenue and Forecast, by Technology

11.5.4.2. Market Revenue and Forecast, by Application

11.5.4.3. Market Revenue and Forecast, by End-user

11.5.5. Rest of LATAM

11.5.5.1. Market Revenue and Forecast, by Technology

11.5.5.2. Market Revenue and Forecast, by Application

11.5.5.3. Market Revenue and Forecast, by End-user

Chapter 12. Company Profiles

12.1. Danaher Corporation

12.1.1. Company Overview

12.1.2. Product Offerings

12.1.3. Financial Performance

12.1.4. Recent Initiatives

12.2. Alcon Laboratories, Inc.

12.2.1. Company Overview

12.2.2. Product Offerings

12.2.3. Financial Performance

12.2.4. Recent Initiatives

12.3. Abbott Laboratories

12.3.1. Company Overview

12.3.2. Product Offerings

12.3.3. Financial Performance

12.3.4. Recent Initiatives

12.4. Hoffman- La Roche Ltd

12.4.1. Company Overview

12.4.2. Product Offerings

12.4.3. Financial Performance

12.4.4. Recent Initiatives

12.5. Becton, Dickinson and Company

12.5.1. Company Overview

12.5.2. Product Offerings

12.5.3. Financial Performance

12.5.4. Recent Initiatives

12.6. Trinity Biotech Plc

12.6.1. Company Overview

12.6.2. Product Offerings

12.6.3. Financial Performance

12.6.4. Recent Initiatives

12.7. Cardinal Health Inc.

12.7.1. Company Overview

12.7.2. Product Offerings

12.7.3. Financial Performance

12.7.4. Recent Initiatives

Chapter 13. Research Methodology

13.1. Primary Research

13.2. Secondary Research

13.3. Assumptions

Chapter 14. Appendix

14.1. About Us

14.2. Glossary of Terms